PGAM2 Regulates Sepsis-Induced Diaphragmatic Atrophy via the JAK2/STAT3 Pathway

Background/Objectives: Sepsis-induced systemic inflammation often leads to diaphragmatic dysfunction and muscle atrophy, contributing to impaired respiratory function. Phosphoglycerate mutase 2 (PGAM2), a key enzyme in glycolysis, plays a significant role in muscle energy metabolism but has not been previously linked to sepsis-induced diaphragmatic dysfunction. This study aims to investigate the role of PGAM2 in sepsis-induced diaphragmatic atrophy and its underlying mechanisms. Methods: A murine sepsis model was established using cecal ligation and puncture (CLP) in C57BL/6 mice. Body and diaphragm weights, along with muscle fiber cross-sectional areas, were measured. PGAM2 expression was evaluated using immunofluorescence, Western blotting, and real-time quantitative polymerase chain reaction (RT-qPCR). In vitro, C2C12 myotubes were treated with tumor necrosis factor alpha (TNF-α), and PGAM2 expression was manipulated via small interfering RNA (siRNA) knockdown and plasmid overexpression. Atrophy markers (MuRF1, MAFbx/atrogin-1) and JAK2/STAT3 pathway activation were assessed. Results: CLP induced significant diaphragmatic atrophy, as reflected by an approximately 38% reduction in diaphragm weight and an approximately 37% decrease in muscle fiber cross-sectional area compared with the sham group. In contrast, PGAM2 protein expression was increased by approximately 105% in septic diaphragms. PGAM2 expression was also significantly elevated in TNF-α-treated myotubes. PGAM2 knockdown resulted in reduced MuRF1 and MAFbx expression, attenuating myotube atrophy, while PGAM2 overexpression exacerbated atrophy. Moreover, PGAM2 knockdown suppressed activation of the JAK2/STAT3 signaling pathway. Conclusions: These findings demonstrate that PGAM2 contributes to sepsis-induced diaphragmatic atrophy through the activation of the JAK2/STAT3 signaling pathway. PGAM2 may therefore serve as a potential therapeutic target for sepsis-associated diaphragmatic dysfunction.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2026-05-09
DOI
https://doi.org/10.3390/biomedicines14051075
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PGAM2 Regulates Sepsis-Induced Diaphragmatic Atrophy via the JAK2/STAT3 Pathway

Yun Chu, Xiaopo Gao, Jinlong Luo, Xinrun Yuan
Biomedicines
Muscle Physiology and Disorders
article

PGAM2 Regulates Sepsis-Induced Diaphragmatic Atrophy via the JAK2/STAT3 Pathway

Yun Chu, Xiaopo Gao, Jinlong Luo, Xinrun Yuan
article en

Abstract

Background/Objectives: Sepsis-induced systemic inflammation often leads to diaphragmatic dysfunction and muscle atrophy, contributing to impaired respiratory function. Phosphoglycerate mutase 2 (PGAM2), a key enzyme in glycolysis, plays a significant role in muscle energy metabolism but has not been previously linked to sepsis-induced diaphragmatic dysfunction. This study aims to investigate the role of PGAM2 in sepsis-induced diaphragmatic atrophy and its underlying mechanisms. Methods: A murine sepsis model was established using cecal ligation and puncture (CLP) in C57BL/6 mice. Body and diaphragm weights, along with muscle fiber cross-sectional areas, were measured. PGAM2 expression was evaluated using immunofluorescence, Western blotting, and real-time quantitative polymerase chain reaction (RT-qPCR). In vitro, C2C12 myotubes were treated with tumor necrosis factor alpha (TNF-α), and PGAM2 expression was manipulated via small interfering RNA (siRNA) knockdown and plasmid overexpression. Atrophy markers (MuRF1, MAFbx/atrogin-1) and JAK2/STAT3 pathway activation were assessed. Results: CLP induced significant diaphragmatic atrophy, as reflected by an approximately 38% reduction in diaphragm weight and an approximately 37% decrease in muscle fiber cross-sectional area compared with the sham group. In contrast, PGAM2 protein expression was increased by approximately 105% in septic diaphragms. PGAM2 expression was also significantly elevated in TNF-α-treated myotubes. PGAM2 knockdown resulted in reduced MuRF1 and MAFbx expression, attenuating myotube atrophy, while PGAM2 overexpression exacerbated atrophy. Moreover, PGAM2 knockdown suppressed activation of the JAK2/STAT3 signaling pathway. Conclusions: These findings demonstrate that PGAM2 contributes to sepsis-induced diaphragmatic atrophy through the activation of the JAK2/STAT3 signaling pathway. PGAM2 may therefore serve as a potential therapeutic target for sepsis-associated diaphragmatic dysfunction.

BiomedicinesVol. 14(5)
Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Openalex Percentile: Top 7%
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.